Factor de Necrosis Tumoral alfa,
Mercaptopurina,
Azatioprina,
Metotrexato,
Enfermedad de Crohn,
Gastroenterología,
Mercaptopurina/uso terapéutico,
Metotrexato/uso terapéutico,
Inducción de Remisión,
Enfermedad de Crohn/tratamiento farmacológico,
Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
These consolidated guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, care and treatme...
Dellinger, R. P;
Levy, M. M;
Rhodes, A;
Annane, D;
Gerlach, H;
Opal, S. M;
Sevransky, J. E;
Sprung, C. L;
Douglas, I. S;
Jaeschke, R;
Osborn, T. M;
Nunnally, M. E;
Townsend, S. R;
Reinhart, K;
Kleinpell, R. M;
Angus, D. C;
Deutschman, C. S;
Machado, F. R;
Rubenfeld, G. D;
Webb, S;
Beale, R. J;
Vincent, J. L;
Moreno, R.
Objective: To provide an update to the “Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock,” last published in 2008. Design: A consensus committee of 68 international experts representing 30 international organizations was convened. Nominal groups were assembled at ...
Takada, Tadahiro;
Strasberg, Steven M;
Solomkin, Joseph S;
Pitt, Henry A;
Gomi, Harumi;
Yoshida, Masahiro;
Mayumi, Toshihiko;
Miura, Fumihiko;
Bu ̈chler, Markus W;
Kiriyama, Seiki;
Yokoe, Masamichi;
Kimura, Yasutoshi;
Tsuyuguchi, Toshio;
Itoi, Takao;
Gabata, Toshifumi;
Higuchi, Ryota;
Okamoto, Kohji;
Jiro, Hata;
Murata, Atsuhiko;
Kusachi, Shinya;
Windsor, John A;
Supe, Avinash N;
Lee, SungGyu;
Chen, Xiao-Ping;
Yamashita, Yuichi;
Hirata, Koichi;
Inui, Kazuo;
Sumiyama, Yoshinobu;
Garden, O. James;
Gouma, Dirk J.
In 2007, the Tokyo Guidelines for the man-agement of acute cholangitis and cholecystitis (TG07) werefirst published in theJournal of Hepato-Biliary-PancreaticSurgery. The fundamental policy of TG07 was to achievethe objectives of TG07 through the development of con-sensus among specialists in this field ...
Esta guía presenta las recomendaciones para el tratamiento de las leishmaniasis cutánea, mucosa y visceral, incluyendo los criterios para el tratamiento local y el nivel de atención en que esas recomendaciones deben estar disponibles....
WHO has developed guidelines on systematic screening for active tuberculosis (TB) based on a thorough review of available evidence. Early detection of TB is essential to further improve health outcomes for people with TB, and to reduce TB transmission more effectively. Systematic screening in high risk g...
This guideline provides an evidence-based recommendation on the use of adult male circumcision devices for HIV prevention in public health programmes in high HIV prevalence, resource-limited settings. It also presents key programmatic considerations for the introduction and use of these devices in public...
WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far...
Adolescents (10–19 years) and young people (20–24 years) continue to be vulnerable, both socially and economically, to HIV infection despite efforts to date. This is particularly true for adolescents — especially girls — who live in settings with a generalized HIV epidemic or who are members of k...
This guideline provides guidance on the principles and evidence-informed recommendations on the nutritional care and support for patients with tuberculosis. Undernutrition increases the risk of tuberculosis and in turn tuberculosis can lead to malnutrition. Undernutrition is therefore highly prevalent am...
